| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 35.74B | 33.22B | 32.85B | 32.23B | 29.45B | 28.95B |
| Gross Profit | 14.33B | 13.64B | 12.27B | 11.21B | 9.71B | 9.47B |
| EBITDA | 7.34B | 7.12B | 6.13B | 5.83B | 4.34B | 6.83B |
| Net Income | 4.95B | 4.73B | 3.94B | 3.75B | 2.48B | 4.55B |
Balance Sheet | ||||||
| Total Assets | 44.63B | 44.88B | 40.36B | 40.94B | 39.15B | 40.26B |
| Cash, Cash Equivalents and Short-Term Investments | 5.93B | 6.62B | 5.64B | 5.82B | 4.88B | 5.33B |
| Total Debt | 9.00B | 9.09B | 7.81B | 8.74B | 8.55B | 6.48B |
| Total Liabilities | 29.26B | 28.24B | 25.30B | 26.79B | 25.88B | 24.30B |
| Stockholders Equity | 14.77B | 16.09B | 14.49B | 13.41B | 12.78B | 15.58B |
Cash Flow | ||||||
| Free Cash Flow | 4.78B | 4.47B | 3.83B | 3.52B | 525.00M | 2.51B |
| Operating Cash Flow | 5.82B | 5.47B | 4.67B | 4.29B | 1.29B | 3.33B |
| Investing Cash Flow | -1.88B | -2.39B | -725.00M | -1.61B | 981.00M | 2.31B |
| Financing Cash Flow | -5.13B | -2.88B | -3.33B | -2.90B | -2.39B | -4.97B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | $127.13B | 61.49 | 42.06% | 0.11% | 28.95% | 130.56% | |
78 Outperform | $7.78B | 15.10 | 16.61% | 0.67% | 5.20% | -0.12% | |
74 Outperform | $180.04B | 27.63 | 33.07% | 0.80% | 8.74% | 21.76% | |
74 Outperform | $8.66B | 23.86 | 15.71% | 0.18% | 15.89% | 3.60% | |
74 Outperform | $27.27B | 35.87 | 25.00% | 1.18% | 7.18% | 14.32% | |
72 Outperform | $26.31B | 33.98 | 19.60% | 0.84% | 34.18% | -15.12% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |